Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CILGAVIMAB\TIXAGEVIMAB Cause Sars-cov-2 test positive? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Sars-cov-2 test positive have been filed in association with CILGAVIMAB\TIXAGEVIMAB. This represents 0.4% of all adverse event reports for CILGAVIMAB\TIXAGEVIMAB.

8
Reports of Sars-cov-2 test positive with CILGAVIMAB\TIXAGEVIMAB
0.4%
of all CILGAVIMAB\TIXAGEVIMAB reports
2
Deaths
2
Hospitalizations

How Dangerous Is Sars-cov-2 test positive From CILGAVIMAB\TIXAGEVIMAB?

Of the 8 reports, 2 (25.0%) resulted in death, 2 (25.0%) required hospitalization.

Is Sars-cov-2 test positive Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CILGAVIMAB\TIXAGEVIMAB. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does CILGAVIMAB\TIXAGEVIMAB Cause?

Covid-19 (521) Drug ineffective (123) Product use issue (94) Fatigue (86) Headache (86) Dyspnoea (84) Pyrexia (81) Nausea (68) Dizziness (64) Breakthrough covid-19 (51)

What Other Drugs Cause Sars-cov-2 test positive?

OCRELIZUMAB (1,421) ADALIMUMAB (1,301) DUPILUMAB (860) NIRMATRELVIR\RITONAVIR (538) LENALIDOMIDE (469) SECUKINUMAB (378) CERTOLIZUMAB PEGOL (361) RISANKIZUMAB-RZAA (335) RITUXIMAB (305) UPADACITINIB (281)

Which CILGAVIMAB\TIXAGEVIMAB Alternatives Have Lower Sars-cov-2 test positive Risk?

CILGAVIMAB\TIXAGEVIMAB vs CILOSTAZOL CILGAVIMAB\TIXAGEVIMAB vs CILTACABTAGENE AUTOLEUCEL CILGAVIMAB\TIXAGEVIMAB vs CIMETIDINE CILGAVIMAB\TIXAGEVIMAB vs CIMZIA CILGAVIMAB\TIXAGEVIMAB vs CINACALCET

Related Pages

CILGAVIMAB\TIXAGEVIMAB Full Profile All Sars-cov-2 test positive Reports All Drugs Causing Sars-cov-2 test positive CILGAVIMAB\TIXAGEVIMAB Demographics